RPC
TMO icon

Rossmore Private Capital’s Thermo Fisher Scientific TMO Stock Holding History

Rossmore Private Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.39M Buy
4,865
+152
+3% +$82.5K 0.21% 84
2025
Q4 		$2.73M Buy
4,713
+340
+8% +$192K 0.24% 77
2025
Q3 		$2.12M Sell
4,373
-73
-2% -$34K 0.23% 82
2025
Q2 		$1.8M Sell
4,446
-206
-4% -$86.1K 0.21% 86
2025
Q1 		$2.31M Buy
4,652
+24
+0.5% +$13K 0.29% 69
2024
Q4 		$2.39M Sell
4,628
-20
-0.4% -$11K 0.3% 70
2024
Q3 		$2.88M Sell
4,648
-6
-0.1% -$3.55K 0.36% 59
2024
Q2 		$2.57M Sell
4,654
-12
-0.3% -$6.88K 0.34% 62
2024
Q1 		$2.71M Sell
4,666
-28
-0.6% -$15.7K 0.35% 63
2023
Q4 		$2.49M Sell
4,694
-1
-0% -$484 0.35% 64
2023
Q3 		$2.38M Sell
4,695
-21
-0.4% -$11.2K 0.36% 59
2023
Q2 		$2.46M Sell
4,716
-63
-1% -$34K 0.37% 59
2023
Q1 		$2.75M Sell
4,779
-240
-5% -$135K 0.43% 56
2022
Q4 		$2.76M Sell
5,019
-222
-4% -$118K 0.44% 57
2022
Q3 		$2.66M Buy
5,241
+22
+0.4% +$12.3K 0.48% 51
2022
Q2 		$2.83M Buy
5,219
+6
+0.1% +$3.3K 0.49% 51
2022
Q1 		$3.08M Hold
5,213
– – 0.48% 56
2021
Q4 		$3.48M Buy
5,213
+144
+3% +$89.9K 0.54% 51
2021
Q3 		$2.9M Sell
5,069
-1
-0% -$549 0.5% 53
2021
Q2 		$2.56M Sell
5,070
-52
-1% -$24.5K 0.44% 57
2021
Q1 		$2.34M Buy
5,122
+284
+6% +$136K 0.44% 59
2020
Q4 		$2.25M Sell
4,838
-112
-2% -$52.5K 0.46% 58
2020
Q3 		$2.19M Buy
4,950
+355
+8% +$147K 0.51% 52
2020
Q2 		$1.67M Buy
4,595
+2,129
+86% +$714K 0.46% 57
2020
Q1 		$699K Buy
+2,466
New +$778K 0.24% 89
2018
Q1 		– Sell
-173
Closed -$32.8K – 375
2017
Q4 		$32.8K Buy
+173
New +$33.1K 0.03% 201

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Rossmore Private Capital's TMO Position: Q1 2026 in Review

Rossmore Private Capital increased its Thermo Fisher Scientific (TMO) stake by 3.2% in Q1 2026, buying an estimated $82.5K and bringing the position to 4,865 shares worth $2.39M. The position accounts for 0.21% of the portfolio, ranked #84.

Rossmore Private Capital first reported a position in TMO in Q4 2017 and has held it in 26 quarters since. The position peaked at $3.48M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Rossmore Private Capital held 4,865 shares of Thermo Fisher Scientific worth $2.39M as of Q1 2026.
  • Rossmore Private Capital bought 152 Thermo Fisher Scientific shares in Q1 2026, an estimated $82.5K.
  • Thermo Fisher Scientific made up 0.21% of Rossmore Private Capital's portfolio in Q1 2026, its #84 holding.
  • Rossmore Private Capital first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 26 quarters since.
  • Rossmore Private Capital's Thermo Fisher Scientific position peaked at $3.48M in Q4 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Rossmore Private Capital's 13F filing for Q1 2026, filed 1 May 2026.